Clinical Trial

Development of the Italian Version of the ICU Mobility Scale (IMS). Cross-cultural Adaptation, Italian Translation, and Validation Study.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Early mobilisation of the patient admitted to intensive care units (ICUs) is essential to prevent Intensive Care Unit Acquired Weakness (ICUAW). It is essential to be able to measure functional mobility in order to evaluate the effectiveness of early mobilisation, both in clinical and research settings. The ICU Mobility Scale (IMS) is a validated scale that can be used to describe the functional level of the critically ill patient according to a categorical scale of 11 items. Each category describes the patient's capabilities from a mobility point of view. The main objective of the study is the validation of the Italian version of the IMS (IMS-it) on a cohort of patients admitted to intensive care. Secondary objective is to assess the concordance between the perception level that the healthcare worker has with regard to the patient's mobility, before the patient is mobilised, expressed with the IMSSecondary study objectives.
Trial Details
NCT Number NCT07195942
Lead Sponsor Istituto Clinico Humanitas
Conditions Muscle Weakness, Critical Illness, Critical Illness Recovery, Acquired Weakness
Enrollment 100 participants
Start Date 2023-06-22
Primary Completion 2025-05-20 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-09-29